Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-056262
Filing Date
2008-10-14
Accepted
2008-10-14 16:01:35
Documents
2
Period of Report
2008-10-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c76016_4x1.html 4  
1 MAIN DOCUMENT DESCRIPTION c76016_4x1.xml 4 9338
2 ADDITIONAL EXHIBITS c76016_99.htm EX-99 3636
  Complete submission text file 0001209191-08-056262.txt   15628
Mailing Address 4400 BISCAYNE BLVD MIAMI FL 33137-3227
Business Address 3055756001
FROST PHILLIP MD ET AL (Reporting) CIK: 0000898860 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 081122369

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4400 BISCAYNE BOULEVARD, 15TH FLOOR MIAMI FL 33137
Business Address 4400 BISCAYNE BOULEVARD, 15TH FLOOR MIAMI FL 33137 305-575-6000
Frost Gamma Investments Trust (Reporting) CIK: 0001380896 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 081122368